US › Healthcare

Adapthealth Corp (AHCO)

US · Healthcare · Medical Devices

$6.71-38.04%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$819.8M
Revenue YoY
+41.2%
Net profit
$-16.0M
Profit YoY
-122.6%
EPS
$-0.05
EPS estimate
$0.01
Net margin
-2.0%

EPS came in at -0.05 against a street estimate of 0.01 — a miss of 600.0%.

Key statistics

Market cap
$1.47B
Forward P/E
12.9
P/B
0.97
Book value
$11.32
EPS (TTM)
$-0.59
52-week high
$13.43
52-week low
$8.51
50-day MA
$10.29
200-day MA
$10.40
Beta
1.45

Analyst view

Analysts rate Adapthealth Corp a buy (6 buy, 2 hold, 0 sell out of 8) with an average price target of $14.14.

Shareholding

Insiders
8.14%
Institutions
106.79%

Largest institutional holders

FundStake
OEP CAPITAL ADVISORS, L.P.11.99%
BlackRock Inc11.72%
Deerfield Management Co8.44%
SkyKnight Capital, L.P.6.31%
FMR Inc5.92%
Reinhart Mahoney Capital Management Inc5.45%
Dimensional Fund Advisors, Inc.5.09%
Vanguard Portfolio Management, LLC4.49%

Recent filings & reports

DocumentDate
Material agreement · Q3 20262026-07-20
Reg FD disclosure · Q3 20262026-07-07
Current report · Q2 20262026-07-02
Shareholder vote results · Q2 20262026-06-22
Quarterly report · Q1 20262026-05-05
Proxy statement · Q2 20262026-04-28
Annual report FY20252026-02-24
Quarterly report · Q3 20252025-11-04

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Adapthealth Corp — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.